Equifax (NYSE: EFX) Stock Analysis: Upgrade, Undervaluation, and Market Outlook

• Equifax (NYSE: EFX) recently received an analyst upgrade to 'Buy' with a significant price target, suggesting substantial potential upside for investors.
• The company demonstrated strong financial performance in Q2 2026, with adjusted earnings and revenues surpassing analyst expectations, contributing to recent share price gains.
• Despite recent insider selling activity, Equifax appears significantly undervalued based on fair value estimates, indicating a potential investment opportunity.

Equifax (NYSE: EFX) is a global data and analytics company, best known as one of the major consumer credit reporting agencies. It gathers and analyzes information to help businesses make critical financial decisions. A key competitor in the information services sector is Information Services Group (NASDAQ: III), which holds a Zacks Rank of #2 (Buy), highlighting its strong market position.

Analyst Simon Clinch of Redburn Partners recently upgraded Equifax to a 'Buy' rating, signaling a positive shift in its stock outlook. He also set a new price target of $235 for the stock. Based on its price of $192.41 at the time, this target suggests a potential upside, or increase in value, of approximately 22.14% for investors seeking growth opportunities.

This positive outlook is supported by the company's recent financial performance. Equifax shares have risen by 12.7% since its last earnings report. The company announced strong second-quarter 2026 results, with adjusted earnings of $2.25 per share and revenues of $1.7 billion, both of which were higher than what analysts had predicted, showcasing robust revenue growth and profitability.

Further investment analysis suggests the stock may be a good value. As highlighted by GuruFocus, Equifax is currently priced 36.7% below its estimated fair value of $288.60, classifying it as a significantly undervalued stock. The company also has a GF Score of 75 out of 100, indicating strong financial health and performance metrics.

However, it is worth noting that company insiders sold $6.90 million worth of shares in the last three months without any corresponding purchases. This type of insider trading activity can sometimes raise questions about internal confidence. Additionally, Equifax holds a Zacks Rank of #3 (Hold), which is a more neutral position than the analyst's 'Buy' rating, offering a balanced perspective on its market insights.